Clinical Trials Logo

Stage I Pulmonary Adenocarcinoma clinical trials

View clinical trials related to Stage I Pulmonary Adenocarcinoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04202614 Completed - Clinical trials for Stage I Pulmonary Adenocarcinoma

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma

Start date: December 2, 2019
Phase:
Study type: Observational

The clinical and derived data from the preoperative computed axial tomography (CT) and Positron Emission Tomography (PET) of patients with pathological stage I pulmonary adenocarcinoma will be analyzed retrospectively, classified according to the current pathological classification IASLC / ATS / ERS of pulmonary adenocarcinoma, subjected to surgical treatment in our Operating Unit between August 2006 and July 2011. A follow-up will be performed on the patients enrolled in the study up to the date of death, and in any case no later than October 31, 2019